Jan Mattsson - 23 Jan 2023 Form 4 Insider Report for ALBIREO PHARMA, INC.

Role
Chief Scientific Officer
Signature
/s/ Jason Duncan, Attorney-in-fact
Issuer symbol
N/A
Transactions as of
23 Jan 2023
Net transactions value
-$8,629
Form type
4
Filing time
23 Jan 2023, 16:11:41 UTC
Previous filing
27 Jan 2023
Next filing
02 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALBO Common Stock Sale $8,629 -197 -0.36% $43.80 54,474 23 Jan 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold pursuant to a Rule 10b5-1 arrangement established in October 2019 to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
F2 Represents 35,524 shares of common stock and 18,950 restricted stock units.